Advertisement
Screener

BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Undistributed Earnings of Foreign Subsidiaries

2.8 / 5 stars · 68/120 Roast Me

BLACK DIAMOND THERAPEUTICS, INC. Undistributed Earnings of Foreign Subsidiaries

BLACK DIAMOND THERAPEUTICS, INC. (BDTX) had Undistributed Earnings of Foreign Subsidiaries of $0 as of 2023-12-31, per its 10-K filed 2024-03-12.

Discontinued › Notes › Income Taxes

us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2024-03-12

  • 2023-12-31: Undistributed Earnings of Foreign Subsidiaries $0.00.
  • 2022-12-31: Undistributed Earnings of Foreign Subsidiaries $0.00.
  • 2021-12-31: Undistributed Earnings of Foreign Subsidiaries $0.00.
Period endUndistributed Earnings of Foreign Subsidiaries
2023-12-31$0.00
10-K · filed 2024-03-12
2022-12-31$0.00
10-K · filed 2023-03-09
2021-12-31$0.00
10-K · filed 2022-03-17

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
LENZ Therapeutics, Inc. (LENZ)United States$0.117B-1.41
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Vaxart, Inc. (VXRT)United States$0.080B3.84